Vimarsana
Biggest News Aggregation in the World

Page 10 - Bardy Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bardy Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bardy Diagnostics Today - Breaking & Trending Today

Hill-Rom Accused of Wrongfully Pulling Plug on Bardy Deal - Vimarsana News

Hill-Rom Accused of Wrongfully Pulling Plug on Bardy Deal

Hill-Rom Accused of Wrongfully Pulling Plug on Bardy Deal Mar 01 2021, 9:28 PM March 01 2021, 9:02 PM March 01 2021, 9:28 PM (Bloomberg) -- Hospital-bed maker Hill-Rom Holdings Inc. is accused of wrongfully pulling the plug on a $375 million buyout of startup Bardy Diagnostics over changes to government reimbursement rates for its cardiac-monitoring system.Officials of Seattle-based Bardy asked a Delaware judge to force Batesville, Indiana-based Hill-Rom to complete the acquisition, saying the proposed Medicare-payment revisions don’t provide a proper lega... (Bloomberg) -- Hospital-bed ...

Hillrom Comments On Novitas Reimbursement Decision - Vimarsana News

Hillrom Comments On Novitas Reimbursement Decision

/PRNewswire/ -- Hillrom (NYSE: HRC) previously announced its intention to acquire Bardy Diagnostics, Inc. (BardyDx), an innovator in digital health and a...

Hillrom to buy cardiac monitoring company Bardy Diagnostics for $375M - Vimarsana News

Hillrom to buy cardiac monitoring company Bardy Diagnostics for $375M

MedCity News Hillrom to buy cardiac monitoring company Bardy Diagnostics for $375M Hillrom will buy Bardy Diagnostics, a startup that makes a wearable ECG patch, for $375 million in cash. Shares0 In another deal for cardiac monitoring, Hillrom (NYSE: HRC) will buy Seattle-based startup Bardy Diagnostics for $375 million. The company, which was founded in 2013 by electrophysiologist Dr. Gust Bardy, makes an electrocardiogram (ECG) patch that can be worn for up to two weeks to help physicians detect arrhythmias. In addition to its technology, Bardy Diagnostics’ 230 employees are expected to...

Hillrom buying cardiac patch maker Bardy Diagnostics for $375M - Vimarsana News

Hillrom buying cardiac patch maker Bardy Diagnostics for $375M

Share Cardiac-monitoring device maker Bardy Diagnostics has agreed to an acquisition by Hillrom, a medical technology provider specializing in smart hospital beds and other connected monitoring tools. The $375 million deal is expected to close during fiscal Q2 2021. Bardy's flagship product is the Carnation Ambulatory Monitor, often referred to as the CAM patch. It's a P-wave signal-capturing wearable that is placed along the sternum, where it can remotely monitor patients’ cardiac activity or detect arrhythmia over a seven-day period. The patch's readings are uploaded to Bardy's compan...